Author:
Kümler Iben,Brünner Nils,Stenvang Jan,Balslev Eva,Nielsen Dorte L.
Publisher
Springer Science and Business Media LLC
Reference72 articles.
1. Brewster AM, Hortobagyi GN, Broglio KR, Kau SW, Santa-Maria CA, Arun B, Buzdar AU, Booser DJ, Valero V, Bondy M, Esteva FJ (2008) Residual risk of breast cancer recurrence 5 years after adjuvant therapy. J Natl Cancer Inst 100(16):1179–1183. doi: 1093/jnci/djn233
2. Cardoso F, Bedard PL, Winer EP, Pagani O, Senkus-Konefka E, Fallowfield LJ, Kyriakides S, Costa A, Cufer T, Albain KS (2009) International guidelines for management of metastatic breast cancer: combination vs. sequential single-agent chemotherapy. J Natl Cancer Inst 101(17):1174–1181. doi: 10.1093/jnci/djp235
3. Roche H, Vahdat LT (2011) Treatment of metastatic breast cancer: second line and beyond. Ann Oncol 22(5):1000–1010. doi: 10.1093/annonc/mdq429
4. Cobleigh MA (2011) Other options in the treatment of advanced breast cancer. Semin Oncol 38(suppl 2):S11–S16. doi: 10.1053/j.seminoncol.2011.04.005
5. Rivera E (2010) Management of metastatic breast cancer: monotherapy options for patients resistant to anthracyclines and taxanes. Am J Clin Oncol 33(2):176–185. doi: 10.1097/COC.0b013e3181931049
Cited by
52 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献